Vigabatrin should be used with caution: Why are doctors cautious in prescribing this drug?
In the field of treatment of refractory epilepsy, especially infantile spasms (West syndrome), although Vigabatrin (Vigabatrin) has shown certain efficacy, doctors are often cautious when prescribing this drug. There are multiple reasons behind this, so doctors may not recommend patients to use Vigabatrin after weighing the pros and cons.
The primary reason is its serious side effect - visual field loss. Research data reveals that among patients who take Vigabatrin for a long time, up to 30% to 50% will experience loss of peripheral vision. This irreversible visual impairment poses a huge threat to patients' daily life and activities. Therefore, for patients with vision problems or eye history, doctors will be particularly careful when prescribing and try to avoid using this drug to avoid aggravating the patient's visual burden.

In addition, the impact of Vigabatrin on the central nervous system cannot be underestimated. Side effects such as drowsiness, dizziness, distraction, and memory loss not only affect patients' learning and work efficiency, but may also have a long-term impact on the growth, development, and cognitive abilities of child patients. The existence of these side effects forces doctors to weigh the possible negative effects when evaluating the suitability of a drug.
Mental health issues are also one reason doctors use Vigabatrin with caution. Some patients may experience symptoms such as mood swings, anxiety, or depression after taking the medication. Especially for patients with a history of mental illness, these side effects may be more significant. Therefore, when deciding whether to use Vigabatrin, doctors will comprehensively consider the patient's mental health status to avoid increasing their psychological burden.
The use of Vigabatrin also requires patients to undergo regular vision examinations and other monitoring, which undoubtedly increases the patient's medical burden and financial pressure. Compared with other drugs with less side effects and stable efficacy, Vigabatrin's disadvantages in these aspects make doctors more inclined to choose safer and more convenient treatment options.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)